Aasma Nalwa

Aasma Nalwa

Auto-generated profile, based on publicly available information

Aasma Nalwa

Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Jodhpur, India

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Kidney360
Verified
Journal Article
Open access
UCUttayan Chakrabarti
Uttayan Chakrabarti
RJRajesh Jhorawat
Rajesh Jhorawat
NBNitin Kumar Bajpai
Nitin Kumar Bajpai
ANAasma Nalwa
Aasma Nalwa
TDTapabrata Das
Tapabrata Das
MCManish Chaturvedy
Manish Chaturvedy
Key Points: Desmopressin is used to reduce bleeding complications in patients with qualitative and quantitative defects in platelet function. Bleeding complications were similar between the two groups. At 24 hours postbiopsy, desmopressin had more hematoma resolution than the control. The evaluation of hematoma in two time frames, 6 and 24 hours, assesses prolonged effect of desmopressin on bleeding complications. Background: Bleeding complications after a kidney biopsy are common in patients with a reduced kidney function. We performed a double-blinded, randomized controlled trial to examine the effect of desmopressin on bleeding complications after a kidney biopsy in patients with an eGFR ≤60 ml/min per 1.73 m2. Methods: We enrolled 152 patients (mean age, 39±15 years; 51% men), of whom 74 were randomized to an interventional group (intranasal desmopressin at 3 mcg/kg 1 hour before the biopsy) and 78 to a control group (intranasal saline). The primary study outcome was the overall frequency of bleeding complications. The secondary outcome was the size of the perinephric hematoma at 6 and 24 hours, assessed by a standardized ultrasound. Results: The baseline characteristics of the two treatment groups were well balanced. Overall, bleeding complications occurred in 64 of 152 (42%) of the study cohort, with 27 of 74 (36%) observed in the desmopressin group and 37 of 78 (47%) in the control group (risk ratio, 0.77; 95% confidence interval, 0.52 to 1.13; P = 0.17). The median hematoma size was similar in both groups at 6 hours (1.5 versus 2.7 ml, P = 0.34) and at 24 hours (1.2 versus 2.0 ml, P = 0.70). The frequency of a perinephric hematoma was similar in the desmopressin and placebo groups at 6 hours (35% versus 46%, P = 0.17), but lower in the desmopressin group at 24 hours (19% versus 36%, P = 0.02). Among the major bleeding complications, the frequency of blood transfusion (8.1% versus 6.4%, P = 0.69) and embolization (2.7% versus 1.3%, P = 0.61) was similar between the two groups. Conclusions: In patients with a reduced kidney function, the administration of desmopressin before a kidney biopsy does not reduce the frequency of bleeding complications or the postbiopsy perinephric hematoma volume at 6 or 24 hours.

21 October 2014 in Cytojournal
Verified
Journal Article
Open access
ASArijit Sen
Arijit Sen
ANAasma Nalwa
Aasma Nalwa
SMSandeep R. Mathur
Sandeep R. Mathur
DJDeepali Jain
Deepali Jain
VIVenkateswaran K. Iyer
Venkateswaran K. Iyer
A 58 years old lady reported with history of progressively increasing lump in the neck. Patient had earlier undergone sub-total thyroidectomy (details not available) in a private institute one year back. Fine needle aspiration cytology (FNAC) of the present lump revealed features of papillary carcinoma thyroid. Patient subsequently underwent total thyroidectomy along with excision of a tumor nodule in the larynx. Gross examination of the specimen revealed a tumor nodule in the right lobe of the thyroid. Microscopic examination of the tumor nodule in the thyroid and larynx revealed a columnar cell variant of papillary carcinoma thyroid. Very few reports describing the cytomorphologic features of this variant of papillary carcinoma are available in the published literature. These reports highlight the absence or paucity of nuclear grooves and intranuclear inclusions in this variant. We describe a case of columnar cell variant of papillary carcinoma where nuclear grooves were prominently seen. In addition, we report the occurrence of rosette-like structures which were brought out better on FNA smears. These rosette-like structures have not been emphasized earlier in the published literature. The cytomorphologic features of this rare variant are also reviewed in this report.

1 June 2021 in The Foot
Verified
Journal Article
Closed access
DJDivesh Jalan
Divesh Jalan
AGAkshat Gupta
Akshat Gupta
AEAbhay Elhence
Abhay Elhence
ANAasma Nalwa
Aasma Nalwa
JBJyotsna Bharti
Jyotsna Bharti
PEPoonam Elhence
Poonam Elhence

20 October 2022 in Ochsner Journal
Verified
Journal Article
Open access
PDF file
DGDeepika Gupta
Deepika Gupta
ANAasma Nalwa
Aasma Nalwa
DVDeepak Vedant
Deepak Vedant
AMAbhishek Malik
Abhishek Malik
AGAmit K. Gupta
Amit K. Gupta
Background: Synovial sarcoma, a malignant mesenchymal tumor, commonly involves the extremities and is rarely found in the pelvis. Cytology with a biphasic pattern can suggest the diagnosis of synovial sarcoma. Case Report: A 32-year-old female presented with complaints of abdominal distension. She was initially evaluated in another hospital where she underwent ultrasound-guided fine needle aspiration cytology (FNAC) of the abdominal mass. The mass was diagnosed as ovarian adenocarcinoma, and the patient underwent 3 cycles of chemotherapy. After 3 months, she was referred to our institute for surgical excision of the mass. Contrast-enhanced computed tomography of the abdomen suggested a well-circumscribed, heterogeneous, solid-cystic mass in the left adnexal region measuring 13.9 × 10 × 9.1 cm and compressing the adjacent structures. No previous radiologic investigations were available. We reviewed the FNAC slide from the outside hospital and made a preliminary diagnosis of biphasic synovial sarcoma. The patient underwent debulking surgery consisting of panhysterectomy with excision of the pelvic mass. Microscopic examination of the pelvic mass showed a biphasic tumor composed of epithelial and mesenchymal components, suggestive of synovial sarcoma. The immunohistochemistry profile supported the morphologic diagnosis. Bilateral ovaries were unremarkable. The patient received 4 cycles of adjuvant chemotherapy and is presently asymptomatic. Conclusion: Although primary pelvic synovial sarcoma is a rare occurrence, this case illustrates that synovial sarcoma can be diagnosed or at least suspected on FNAC. Because of the importance of adjuvant chemotherapy, synovial sarcoma must be high on the list of differential diagnoses of high-grade intra-abdominal masses.

4 July 2020 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
SBSushma Bharti
Sushma Bharti
ANAasma Nalwa
Aasma Nalwa
MRMadhubala Rajendran
Madhubala Rajendran
MRMeenakshi Rao
Meenakshi Rao
PEPoonam Abhay Elhence
Poonam Abhay Elhence

1 June 2021 in Diagnostic Cytopathology
Verified
Journal Article
Closed access
PDF file
DGDeepika Gupta
Deepika Gupta
AGAanchal Gupta
Aanchal Gupta
ANAasma Nalwa
Aasma Nalwa
TYTaruna Yadav
Taruna Yadav
RCRamkaran Chaudhary
Ramkaran Chaudhary
MRMeenakshi Rao
Meenakshi Rao